BIOPHARMA HOLDING ApS: Financial statements 2022
CVR: 35206086
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,193,605 and a net result of DKK -29,721,851 compared with DKK 12,015,703 the year before. That is an increase of 69.5% compared with the year before. Equity in the 2022 report amounted to DKK 128,556,041. The solvency ratio was 93.3%.
- Gross Profit
- DKK 1,193,605
- Profit/Loss
- DKK -29,721,851
- Equity
- DKK 128,556,041
- Total Assets
- DKK 137,803,087
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.2M | -29.7M | 128.6M | - |
| 2021 | - | 704K | 12M | 158.3M | - |
| 2020 | - | 591K | 1.5M | 146.3M | 1 |
| 2019 | - | 385K | 24.4M | 144.8M | 0 |
| 2018 | - | 405K | 1.4M | 120.4M | 0 |
Official annual report
Keep an eye on BIOPHARMA HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOPHARMA HOLDING ApS has published its annual report for 2021. Gross profit came to DKK 704,103, and the net result was DKK 12,015,703.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.